Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 234 results for "Zohydro"

Zogenix: A Strong Turnaround For 2015
Seeking Alpha

Zogenix (ZGNX) Gets FDA Approval of Zohydro ER

Shares of Zogenix, Inc. (Nasdaq:ZGNX), are up more than 5% to $1.42 in after-hours trading Friday following the company's announcement that the FDA has approved a new formulation of Zohydro® ER (hydrocodone bitartrate) Extended-Release Capsules, ... Wall Street Pit, 11 hours ago
PDUFA date approaches for Zohydro sNDA Seeking Alpha, 2 days ago
[x]  

1 images for "Zohydro"

Seeking Alpha, 1 week ago

Reports Outline FDA Actions Findings from Harvard University [Zohydro ? Approval by Food and Drug Administration: Controversial or Frightening?]

By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on FDA Actions. According to news reporting out of Boston, Massachusetts, by NewsRx editors, research stated, "The actions and regulations of the Food and Drug ...
 Pharmacy Choice1 month ago
FOXNews.com

FDA approves Purdue's abuse-resistant Hysingla, a hydrocodone pill aimed at knocking off Zohydro

The FDA has faced a firestorm of criticism since approving Zogenix's ($ZGNX) superstrength painkiller Zohydro last year, drawing outcry from lawmakers and industry groups concerned with the drug's all-hydrocodone formula with no features to deter ...
 FiercePharma2 months ago Purdue wins a pain pill approval with Zohydro in its crosshairs  FierceBiotech2 months ago FDA approves abuse-resistant hydrocodone painkiller, offering alternative to Zohydro  Yahoo! Canada2 months ago Purdue Pharma Wins U.S. Approval for Abuse-Deterrent Painkiller  Washington Post2 months ago
[x]  

Zogenix Rating Reiterated by Brean Capital (NASDAQ:ZGNX)

Zogenix (NASDAQ:ZGNX) s stock had its buy rating reaffirmed by analysts at Brean Capital in a research report issued to clients and investors on Tuesday. Shares of Zogenix ( NASDAQ:ZGNX ) opened at 1.31 on Tuesday. Zogenix has a 1-year low of ...
 SleekMoney1 week ago Brean Capital Initiates Coverage On Zogenix  Benzinga.com1 month ago

The Evils of Big Pharma Exposed

What's wrong with America is what's wrong with Big Pharma. And what's wrong with Big Pharma is what's wrong with America. This circular reality is aimed to be thoroughly covered in this presentation. This is the story of how Big Pharma seeks ...
 Global Research1 week ago

2 Upcoming Winners in 2015's Hottest Sector

It has been a very bumpy start to the New Year for investors as volatility has increased substantially. Oil prices continue to plunge and the U.S. dollar continues to strengthen, roiling sectors of the market. However, that doesn't change the fact ...
 Investors Alley2 weeks ago
MedPage Today

No Easing of Opioid Death Toll (CME/CE)

Action Points Deaths due to poisoning from prescription opioids rose in 2013 as did heroin deaths, despite years of policy changes and increasing awareness of abuse and addiction. Note that the data showed a rise in both prescriptions and abuse ...
 MedPage Today2 weeks ago

The Wendy Williams Show Tuesday 06 January 2015 9:00PM GMT | BET (135)

It's a new season of The Wendy Williams show. Hosted by the unique and entertaining Wendy Williams this talk show features a mix of celebrity interviews and performances with guests from TV, film, music and sports. During the popular segments "Ask ...
 Business Ghana3 weeks ago

Zogenix 2015 Expectations and Developments Drive Price Upward: Analyst Report Issued by BrokerBank Securities, Inc.

NEW YORK , Jan. 5,2015 /PRNewswire/ --Zogenix Inc. ( NASDAQ: ZGNX ) is a California -based pharmaceutical company that develops and commercializes therapies for the treatment of central nervous system disorders and pain. The company's two main ...
 Tamar Securities3 weeks ago
[x]  

FDA approves Hysingla with 
abuse-deterrent properties

FDA announced in November 2014 the approval of an extended-release, once-daily hydrocodone product (Hysingla ER—Purdue Pharma) with abuse-deterrent properties. 
 The product is the fourth recognized by FDA as having tamper-resistant ...
 Pharmacist.com4 weeks ago FDA approves Hysingla with abuse-deterrent properties  Pharmacist.com1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less